SCHEMBL9033418

SCHEMBL9033418

CCCCc1nn(-c2ccccc2C(=O)OC)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9034260 0.91 AGTR1 (0.59) —
SCHEMBL9033249 0.91 AGTR1 (0.52) —
SCHEMBL9032073 0.90 — —
SCHEMBL9033234 0.88 AGTR1 (0.52) —
SCHEMBL9032091 0.88 AGTR1 (0.60) —
SCHEMBL9031785 0.88 AGTR1 (0.54) —
SCHEMBL9033470 0.87 AGTR1 (0.55) —
SCHEMBL9033733 0.87 AGTR1 (0.60) —
SCHEMBL9031470 0.86 AGTR1 (0.55) —
SCHEMBL9031930 0.86 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0412594-B1 Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists MERCK & CO INC (US) 1996-01-03 — — EP disclosed
EP-0412594-A2 Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists MERCK & CO. INC. (US) 1991-02-13 — — EP disclosed
Send feedback